Strong Immune Privileges of MSC and Other Nes-GFP<sup>+</sup> Progenitors in Bone Marrow of Transgenic Mice

Immune privileges (IPs) have been demonstrated for several types of quiescent stem cells (SCs) in adult mammalian organisms. Cancer SCs (CSCs) also manifest IPs, which is one of the main concerns in cancer therapy. To elucidate the strength of non-pathological SCs IPs, we implanted bone marrow (BM) of transgenic N-GFPCF1 mice under the renal capsule of non-transgenic mice immunized with enhanced green fluorescent protein (GFP). We show that Nes-GFP<sup>+</sup> mesenchymal SCs (MSCs) and other subpopulations of Nes-GFP<sup>+</sup> progenitors in mouse BM have strong IPs, since they survive for at least six wk despite targetedly activated against them full immune system. We also demonstrate that MSCs retain their functionality after exposition to such immune pressure by successful retransplantation of the foci into the secondary non-immunized recipients. We suggest that nestin could be a marker for a wide spectrum of quiescent SCs with strong IPs, including CSCs.

Authors

Institutions

Publication Details

Journal
Immune Network
Published
2025-01-01
DOI
https://doi.org/10.4110/in.2025.25.e20
Citations
1
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
1.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Strong Immune Privileges of MSC and Other Nes-GFP+ Progenitors in Bone Marrow of Transgenic Mice

Dmitriy Karpenko, Н. М. Капранов, Alexey Bigildeev
1 citations
Immune Network
Hematopoietic Stem Cell Transplantation
1.77
article

Strong Immune Privileges of MSC and Other Nes-GFP+ Progenitors in Bone Marrow of Transgenic Mice

Dmitriy Karpenko, Н. М. Капранов, Alexey Bigildeev
article en
1 citations

Abstract

Immune privileges (IPs) have been demonstrated for several types of quiescent stem cells (SCs) in adult mammalian organisms. Cancer SCs (CSCs) also manifest IPs, which is one of the main concerns in cancer therapy. To elucidate the strength of non-pathological SCs IPs, we implanted bone marrow (BM) of transgenic N-GFPCF1 mice under the renal capsule of non-transgenic mice immunized with enhanced green fluorescent protein (GFP). We show that Nes-GFP<sup>+</sup> mesenchymal SCs (MSCs) and other subpopulations of Nes-GFP<sup>+</sup> progenitors in mouse BM have strong IPs, since they survive for at least six wk despite targetedly activated against them full immune system. We also demonstrate that MSCs retain their functionality after exposition to such immune pressure by successful retransplantation of the foci into the secondary non-immunized recipients. We suggest that nestin could be a marker for a wide spectrum of quiescent SCs with strong IPs, including CSCs.

Immune NetworkVol. 25(3)
Sechenov University (RU), Lomonosov Moscow State University (RU), Kurchatov Institute (RU), National Research Center for Hematology Russian Academy of Medical Sciences (RU), Vavilov Institute of General Genetics (RU)
Russian Science Foundation, Russian Academy of Sciences
Openalex Percentile: Top 15%
Hematopoietic Stem Cell Transplantation
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.